SCHEMBL16640319

SCHEMBL16640319

CC(C)c1ccc(-n2c3ccccc3c3ncccc32)nc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.33
NPC1 O15118 3/20 0.33
HSP90AA1 P07900 1/20 0.33
IDO1 P14902 1/20 0.33
KDM4E B2RXH2 4/20 0.33
MAPT P10636 3/20 0.33
HTT P42858 3/20 0.33
RAB9A P51151 2/20 0.33
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
ATM Q13315 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MPI P34949 1/20 0.32
SLC6A2 P23975 1/20 0.32
REN P00797 1/20 0.32
ACACB O00763 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12383093 0.87 KMT2A (0.38) GRM4L3MBTL1NPC1KDM4EMAPT
SCHEMBL16640328 0.87 GRM4 (0.40) GRM4L3MBTL1NPC1KDM4EHTT
SCHEMBL16640316 0.84 GRM4 (0.35) GRM4L3MBTL1NPC1KDM4EMAPT
SCHEMBL21726279 0.83 FFAR4 (0.35)
SCHEMBL16644613 0.82 NPC1 (0.40) L3MBTL1NPC1HSP90AA1KDM4EMAPT
SCHEMBL16640348 0.82 L3MBTL1 (0.41) L3MBTL1NPC1HSP90AA1IDO1KDM4E
SCHEMBL15161560 0.81 GRM4 (0.30) GRM4
SCHEMBL16640320 0.81 MKNK1 (0.35) GRM4IDO1MAPTSLC6A2
SCHEMBL16640315 0.81 MAOA (0.43) GRM4SLC6A2SMO
SCHEMBL13316731 0.78 UTS2R (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11189808-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-11-30 US disclosed
US-20200152891-A1 PLATINUM COMPLEXES AND DEVICES UNIV ARIZONA STATE (US) 2020-05-14 US disclosed
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-10-10 US disclosed
US-9947881-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-04-17 US disclosed
US-9947881-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-04-17 US disclosed
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-01-12 US disclosed
US-9385329-B2 Platinum complexes and devices Arizona Board of Regents on behalf of Arizona State University and Universal Display Corporation (US) 2016-07-05 US disclosed
US-20150105556-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11189808-B2 Platinum complexes and devices OXA1L, OCIAD1, OCIAD2 GRM4 3031/4885L3MBTL1 1502/4885NPC1 2152/4885
US-20200152891-A1 PLATINUM COMPLEXES AND DEVICES OXA1L, OCIAD1, OCIAD2 GRM4 3031/4885L3MBTL1 1502/4885NPC1 2152/4885
US-20190312210-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLCO4C1, SLCO2A1, SLCO1A2 GRM4 2496/4885L3MBTL1 2377/4885NPC1 125/4885
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES OXA1L, OCIAD1, OCIAD2 GRM4 3031/4885L3MBTL1 1502/4885NPC1 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.